The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Fluoropyrimidine-based adjuvant chemotherapy in patients with resected biliary tract cancers.
Se-Il Go
No relevant relationships to disclose
Jung Hun Kang
No relevant relationships to disclose
Chi-Young Jeong
No relevant relationships to disclose
Gyeong-won Lee
No relevant relationships to disclose
Hoon-Gu Kim
No relevant relationships to disclose
Myoung-Hee Kang
No relevant relationships to disclose
Haa-na Song
No relevant relationships to disclose